Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Algorithme Pharma USA

Algorithme Pharma USA?uq=3Oe4kK1Z
1976 FOUNDED
M&A STATUS
61-70 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of clinical contract research services for pharmaceutical companies, generic drug companies, and the bio-pharmaceutical industry in the United States and worldwide. The company's services include business development, scientific affairs, review board, project management, clinic, data management, bioanalytical, protocol preparation, support, and quality assurance. It conducts various types of clinical trials and studies, such as bioavailability, special populations, first in human trials, definitive/thorough QTc evaluations, dose ranging, drug/drug interactions, drug/alcohol interactions, age/gender, pharmacodynamics, and pharmacokinetics.

Formerly Known As
Bioanalytical Systems (Clinical Pharmacology Research Unit)
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 302 West Fayette Street
  • Baltimore, MD 21201
  • United States

+1 (410) 000-0000

Algorithme Pharma USA Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Algorithme Pharma USA‘s full profile, request access.

Request full access to PitchBook

Algorithme Pharma USA Executive Team (7)

Name Title Board
Seat
Contact
Info
James Carlson President & Chief Executive Officer

6 Former Executives

You’re viewing 1 of 7 executives. Get the full list »